Massey researcher awarded $3 million to study the effect of blood cell stimulation on the development of adolescent leukemia and bone marrow disorders
Massey program leader, researcher and physician Seth Corey M.D., M.P.H., was awarded more than $3 million in grant funding from the National Heart, Lung and Blood Institute (NHLBI) for a four-and-a-half-year study on the evolution of a blood cell deficiency to pre-leukemia. The research aims to determine whether a common treatment for the condition acts as a contributor to the development of leukemia or other life-threatening bone marrow disorders.
A second first birthday
Six months after her original cancer diagnosis, Ann Moore sat in a clinic exam room anticipating the results from her CT scan. In February 2015, she had received the last of 18 weeks worth of chemotherapy treatment for stage IV ovarian cancer, and now waited anxiously to hear if it had been effective.
VCU Massey researchers uncover process that drives prostate cancer metastasis
Researchers at VCU Massey Cancer Center have uncovered a novel function of the gene PLK1 (polo-like kinase 1) that helps prostate cancer cells metastasize (spread) to other parts of the body. This mechanism highlights new potential targets for cancer therapies and challenges the previous understanding of PLK1’s role in cancer growth and progression.
Health fair connects patients and families with Massey’s integrative health resources
On Tuesday, March 29, Massey hosted an integrative health resource fair for cancer patients and their family and caregivers to help better inform them of Massey’s integrative health services.
Annual Massey conference brings together Virginia cancer experts
Oncologists and cancer clinical researchers from across Virginia came together at VCU Massey Cancer Center’s 4th annual Cancer Symposium and Clinical Research Affiliation Network Retreat on April 8 and 9 at the Wyndham Virginia Crossings Hotel and Conference Center in Glen Allen, VA.